Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Bayesian single‐to‐double arm transition design using both short‐term and long‐term endpoints52
Estimators for handling COVID‐19‐related intercurrent events with a hypothetical strategy23
On Some Modeling Issues in Estimating Vaccine Efficacy20
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials17
Issue Information16
16
Conditional power and information fraction calculations at an interim analysis for random coefficient models15
14
A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection12
Informed decision‐making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments12
Inverse probability of censoring weighting for visual predictive checks of time‐to‐event models with time‐varying covariates12
Issue Information11
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation11
Evaluating response‐adaptive randomization procedures for recurrent events and terminal event data using a composite endpoint11
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation11
0.02055811882019